৳ ০.০০
আপনার সব স্বাস্থ্যসেবার সমাধান — এখন এক জায়গাতেই
১০৬৫৭
info@shukhee.com
টেলিকম ভবন, ৫৩/১, বক্স নগর, ঢাকা-১২১৬
৳ ০.০০
১০৬৫৭
info@shukhee.com
টেলিকম ভবন, ৫৩/১, বক্স নগর, ঢাকা-১২১৬


Quantity:
Products
Payment
Delivery
Indications Arie tablet is an adenosine receptor antagonist indicated as adjunctive treatment to levodopa/carbidopa in adult patients with Parkinson’s disease experiencing “off” episodes.
Pharmacology Istradefylline is a selective adenosine A2A receptor inhibitor. These receptors are found in the basal ganglia, a brain region affected in Parkinson’s disease and involved in motor control. A2A receptors are expressed on GABAergic medium spiny neurons in the indirect striato-pallidal pathway. By reducing GABAergic activity in this pathway, motor function improves. Istradefylline has 56 times greater affinity for A2A receptors than A1 receptors.
Dosage & Administration
Recommended dose: 20 mg orally once daily
May increase to 40 mg once daily based on need and tolerability
Smokers (≥20 cigarettes/day or equivalent tobacco): 40 mg once daily
Hepatic impairment:
Moderate: Max 20 mg once daily
Severe: Avoid use
Pediatric use: Not established
Interactions
With strong CYP3A4 inhibitors (e.g., Ketoconazole): Max dose 20 mg once daily
Avoid use with strong CYP3A4 inducers (e.g., Rifampicin)
Contraindications
Hypersensitivity to Istradefylline or components
Severe hepatic impairment
Side Effects Most common adverse reactions: Dyskinesia, dizziness, constipation, nausea, hallucination, insomnia
Pregnancy & Lactation
Pregnancy: Not recommended; may cause fetal harm
Lactation: Unknown if present in breast milk; caution advised in nursing women
Precautions & Warnings
Monitor for dyskinesia or worsening of existing dyskinesia
If hallucinations, psychotic behavior, impulse control disorders, or compulsive behaviors occur, consider dose reduction or discontinuation
Overdose Effects Limited clinical experience. If overdose occurs, discontinue Arie and provide supportive treatment as indicated.
N/A






N/A





